UCBG 2-08: 5-year efficacy results from the UNICANCER-PACS08 randomised phase III trial of adjuvant treatment with FEC100 and then either docetaxel or ixabepilone in patients with early-stage, poor prognosis breast cancer

Auteurs

Mario Campone, Magali Lacroix-Triki, Lise Roca, Marc Spielmann, Hans Wildiers, Paul Cottu, Pierre Kerbrat, Christelle Levy, Isabelle Desmoulins, Thomas Bachelot, Tan Winston, Jean-Christophe Eymard, Lionel Uwer, Francois P. Duhoux, Didier Verhoeven, Dominique Jaubert, David Coeffic, Hubert Orfeuvre, Jean Luc Canon, Bernard Asselain, Anne-Laure Martin, Jerome Lemonnier, Henri Roché